Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments

被引:88
作者
Grände, PO
Asgeirsson, B
Nordström, CH
机构
[1] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Anesthesiol & Crit Care, S-22185 Lund, Sweden
关键词
blood-brain barrier; brain edema; brain trauma; colloid osmotic pressure; hydrostatic capillary pressure; microdialysis; Starling formula;
D O I
10.1034/j.1399-6576.2002.460802.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Opinions differ widely on the various treatment protocols for sustained increase in intracranial pressure (ICP). This review focuses on the physiological volume regulation of the intracranial compartments. Based on these mechanisms we describe a protocol called 'volume-targeted' ('Lund concept') for treatment of increased ICP. The driving force for transcapillary fluid exchange is determined by the balance between effective transcapillary hydrostatic and osmotic pressures. Fluid exchange across the intact blood-brain barrier (BBB) is counteracted by the low permeability to crystalloids (mainly Na+ and Cl-) combined with the high osmotic pressure (5500 mmHg) on both sides of the BBB. This contrasts to most other capillary regions where the osmotic pressure is mainly derived from the plasma proteins (approximately 25 mmHg). Accordingly, the level of the cerebral perfusion pressure (CPP) is of less importance under physiological conditions. In addition cerebral intracapillary hydrostatic pressure (and cerebral blood flow) is physiologically tightly autoregulated, and variations in systemic blood pressure are generally not transmitted to these capillaries. If the BBB is disrupted, transcapillary water transport will be determined by the differences in hydrostatic and colloid osmotic pressure between the intra- and extracapillary compartments. Under these pathological conditions, pressure autoregulation of cerebral blood flow is likely to be impaired and intracapillary hydrostatic pressure will depend on variations in systemic blood pressure. The volume-targeted 'Lund concept' can be summarized under four headings: (1) Reduction of stress response and cerebral energy metabolism; (2) reduction of capillary hydrostatic pressure; (3) maintenance of colloid osmotic pressure and control of fluid balance; and (4) reduction of cerebral blood volume. The efficacy of the protocol has been evaluated in experimental and clinical studies regarding the physiological and biochemical (utilizing intracerebral microdialysis) effects, and the clinical experiences have been favorable.
引用
收藏
页码:929 / 941
页数:13
相关论文
共 99 条
[1]   CEREBRAL EFFECTS OF EXTENDED HYPERVENTILATION IN UNANESTHETIZED GOATS [J].
ALBRECHT, RF ;
MILETICH, DJ ;
RUTTLE, M .
STROKE, 1987, 18 (03) :649-655
[2]  
[Anonymous], 2000, COCHRANE DB SYST REV
[3]  
[Anonymous], J NEUROSURG
[4]   A NEW THERAPY OF POSTTRAUMA BRAIN EDEMA BASED ON HEMODYNAMIC PRINCIPLES FOR BRAIN VOLUME REGULATION [J].
ASGEIRSSON, B ;
GRANDE, PO ;
NORDSTROM, CH .
INTENSIVE CARE MEDICINE, 1994, 20 (04) :260-267
[5]   EFFECTS OF ARTERIAL AND VENOUS-PRESSURE ALTERATIONS ON TRANSCAPILLARY FLUID EXCHANGE DURING RAISED TISSUE PRESSURE [J].
ASGEIRSSON, B ;
GRANDE, PO .
INTENSIVE CARE MEDICINE, 1994, 20 (08) :567-572
[6]   CEREBRAL HEMODYNAMIC-EFFECTS OF DIHYDROERGOTAMINE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN-LESIONS [J].
ASGEIRSSON, B ;
GRANDE, PO ;
NORDSTROM, CH ;
MESSETER, K ;
SJOHOLM, H .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1995, 39 (07) :922-930
[7]   EFFECTS OF HYPOTENSIVE TREATMENT WITH ALPHA(2)-AGONIST AND BETA(1)-ANTAGONIST ON CEREBRAL HEMODYNAMICS IN SEVERELY HEAD-INJURED PATIENTS [J].
ASGEIRSSON, B ;
GRANDE, PO ;
NORDSTROM, CH ;
BERNTMAN, L ;
MESSETER, K ;
RYDING, E .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1995, 39 (03) :347-351
[8]   Serial determinations of cerebral water content by magnetic resonance imaging after an infusion of hypertonic saline [J].
Bacher, A ;
Wei, JN ;
Grafe, MR ;
Quast, MJ ;
Zornow, MH .
CRITICAL CARE MEDICINE, 1998, 26 (01) :108-114
[9]   Human albumin therapy of acute ischemic stroke - Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window [J].
Belayev, L ;
Liu, YT ;
Zhao, WZ ;
Busto, R ;
Ginsberg, MD .
STROKE, 2001, 32 (02) :553-560
[10]   Cochrane report - A systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage [J].
Bereczki, D ;
Liu, M ;
do Prado, GF ;
Fekete, I .
STROKE, 2000, 31 (11) :2719-2722